Bio-Path Holdings Inc

Bio-Path Holdings, a biotech company focused on RNAi nanoparticle drug development, faces market volatility and challenges, but its innovative approach to oncology treatment holds long-term potential.

Bio-Path Holdings, a biotech company focused on cancer treatment, faces significant challenges due to market volatility, but its innovative RNAi technology offers hope for advancing cancer treatment.